Electrosurgical instrument with axially-spaced electrodes

Information

  • Patent Grant
  • 6749604
  • Patent Number
    6,749,604
  • Date Filed
    Thursday, March 30, 2000
    24 years ago
  • Date Issued
    Tuesday, June 15, 2004
    20 years ago
Abstract
A bi-polar electrocautery needle comprising an inner electrode on outer electrode and recoverable insulating-locking member for insulting the electrode from one another and locking them into relative position to one another. And the method of making the bi-polar electrocautery needle in accordance with this invention, the steps including: expanding recoverable dielectric material over an inner electrode; and recovering the material between the electrodes for insulating and locking the electrodes into relative position with one another.
Description




BACKGROUND OF THE INVENTION




1. Field of the Invention




The present invention relates generally to the field of electrosurgery and, more particularly, to surgical devices and methods which employ very high frequency electrodes comprising an array of individual, isolated electrode terminals.




The field of electrosurgery includes a number of loosely related surgical techniques which have in common the application of electrical energy to modify the structure or integrity of patient tissue. Electrosurgical procedures usually operate through the application of very high frequency currents to cut or ablate tissue structures, where the operation can be monopolar or bipolar. Monopolar techniques rely on external grounding of the patient, where the surgical device defines only a single electrode pole. Bipolar devices comprise both electrodes for the application of current between their surfaces.




Electrosurgical procedures and techniques are particularly advantageous since they generally reduce patient bleeding and trauma associated with cutting operations. Additionally, electrosurgical ablation procedures, where tissue surfaces and volume may be reshaped, cannot be duplicated through other treatment modalities.




The use of electrosurgical procedures in electrically conductive environments, however, can be problematic. For example, many arthroscopic procedures require flushing of the region to be treated with isotonic saline (also referred to as normal saline), both to maintain an isotonic environment and to keep the field of viewing clear. The presence of saline, which is a highly conductive electrolyte, can cause shorting of the electrosurgical electrode in both monopolar and bipolar modes. Such shorting causes unnecessary heating in the treatment environment and can further cause non-specific tissue destruction.




Present electrosurgical techniques used for tissue ablation also suffer from an inability to control the depth of necrosis in the tissue being treated. Most electrosurgical devices rely on creation of an electric arc between the treating electrode and the tissue being cut or ablated to cause the desired localized heating. Such arcs, however, often create very high temperatures causing a depth of necrosis greater than 500 μm, frequently greater than 800 μm, and sometimes as great as 1700 μm. The inability to control such depth of necrosis is a significant disadvantage in using electrosurgical techniques for tissue ablation, particularly in arthroscopic procedures for ablating and/or reshaping fibrocartilage, articular cartilage, meniscal tissue, and the like.




In an effort to overcome at least some of these limitations of electrosurgery, laser apparatus have been developed for use in arthroscopic and other procedures. Lasers do not suffer from electrical shorting in conductive environments, and certain types of lasers allow for very controlled cutting with limited depth of necrosis. Despite these advantages, laser devices suffer from their own set of deficiencies. In the first place, laser equipment can be very expensive because of the costs associated with the laser light sources. Moreover, those lasers which permit acceptable depths of necrosis (such as excimer lasers, erbium:YAG lasers, and the like) provide a very low volumetric ablation rate, which is a particular disadvantage in cutting and ablation of fibrocartilage, articular cartilage, and meniscal tissue. The holmium:YAG and Nd:YAG lasers provide much higher volumetric ablation rates, but are much less able to control depth of necrosis than are the slower laser devices. The CO


2


lasers provide high rate of ablation and low depth of tissue necrosis, but cannot operate in a liquid-filled cavity.




For these reasons, it would be desirable to provide improved apparatus and methods for efficiently cutting and ablating tissue, particularly fibrocartilage, articular cartilage, meniscal tissue, and the like in arthroscopic and other procedures. Such apparatus and methods should be able to selectively cut and ablate tissue and other body structures in electrically conductive environments, particularly regions which are filled with blood, irrigated with saline, or the like. Such apparatus and methods should be able to perform cutting and ablation of tissues, particularly fibrocartilage, articular cartilage, meniscal tissue, and the like, while limiting the depth so necrosis and tissue adjacent to the treatment site. Such apparatus and methods should be amenable to precise control over the energy flux levels applied to the treatment region, and should be able to provide energy densities sufficient to provide rapid cutting and ablation. The devices should be adaptable to a wide variety of purposes, particularly including both small and large electrode surfaces, and rigid and flexible structures which can be used in open surgery, arthroscopic surgery, and other minimally invasive surgical techniques.




2. Description of the Background Art




Devices incorporating radio frequency electrodes for use in electrosurgical and electrocautery techniques are described in Rand et al. (1985)


J. Arthro. Surg


. 1:242-246 and U.S. Pat. Nos. 5,281,216; 4,943,290; 4,936,301; 4,593,691; 4,228,800; and 4,202,337. U.S. Pat. No. 5,281,216 describes a bipolar device having an active electrode coated with a high impedance material where the differential impedance between the active and return electrodes is optimized to provide a desired cutting effect. Vascular catheters and devices incorporating radio frequency electrodes to assist in penetrating atheroma and plaque are described in U.S. Pat. Nos. 5,281,218; 5,125,928; 5,078,717;4,998,933; and 4,976,711, and PCT publications WO 93/20747 and WO 90/07303, the latter of which describes a catheter having four isolated electrode surfaces at its distal end. Electrosurgical power supplies including power controls and/or current limiting systems are described in U.S. Pat. No. 5,267,997 and PCT publication WO 93/20747. Surgical lasers for cutting and ablation in arthroscopic and other procedures are described in Euchelt et al. (1991) Surgery and Medicine II: 271-279; and U.S. Pat. Nos. 5,147,354; 5,151,098; 5,037,421; 4,968,314; 4,785,806; 4,737,678; 4,736,743; and 4,240,441.




SUMMARY OF THE INVENTION




The present invention provides methods and apparatus for selectively applying electrical energy to structures within a patient's body. The methods and apparatus are particularly useful for performing electrosurgical interventions, such as ablation and cutting of body structures, through the controlled application of high frequency electrical voltages and currents.




Apparatus according to the present invention comprise electrosurgical probes including a shaft having a proximal end, a distal end, an electrode array disposed near the distal end of the shaft, and a connector disposed near the proximal end of the shaft. The shaft will be of a type suitable for use in open and/or minimally invasive surgical procedures, such as arthroscopic, laparoscopic, thoracoscopic, and other endoscopic procedures. The shaft may be rigid, flexible, or include both rigid and flexible portions, and will be generally suitable for manipulation by the treating physician from the proximal end. A common electrode may optionally be provided on the shaft, typically being mounted over the exterior of the shaft and spaced proximally from the electrode array, and preferably being covered with a perforate, electrically non-conductive shield to protect against accidental tissue contact. The electrode array includes a plurality of electrically isolated electrode terminals disposed over a contact surface, which may be a planar or non-planar surface and which may be located at the distal tip or over a lateral surface of the shaft, or over both the tip and lateral surface(s). Such electrode arrays are particularly useful for performing electrosurgical ablation, as described in more detail below. In addition to planar and other surfaces, the electrode array may be arranged in a linear pattern, which is particularly useful as a blade for electrosurgical cutting procedures. The electrode array will include at least two and preferably more electrode terminals, and may further comprise a temperature sensor. The connector permits electrical coupling of the electrode terminals, and optionally temperature sensor, to a high frequency power supply and optionally temperature monitor and/or controller or operation of the probe.




The use of such electrode arrays in electrosurgical procedures is particularly advantageous as it has been found to limit the depth of tissue necrosis without substantially reducing power delivery and ablation rates. Heretofore, increased power delivery with electrosurgical devices has generally been achieved by increasing monolithic electrode area. The resulting large electrode surfaces, however, cause tissue necrosis to a depth which varies proportionally with the width and area of the electrode surface. The present invention provides a more controlled necrosis depth by utilizing a plurality of isolated electrode terminals, where the terminals are preferably laterally spaced-apart by a distance from one-tenth to one terminal diameter, with spacing between larger electrode terminals generally being at the lower end of the range. Such spacing provides adequate power delivery and ablation rates without excessive tissue necrosis, which is usually limited to a depth less than one electrode terminal diameter.




Apparatus according to the present invention further include an electrosurgical high frequency power supply comprising a multiplicity of independent current sources and a connector which mates with a corresponding connector on the electrosurgical probe. The current sources preferably comprise passive or active current limiting circuit structures in parallel with each other and in series with a common voltage source within the power supply. Passive current limiting circuit structures may include inductor(s), capacitor(s), and/or resistor(s) in known circuit configurations. In all cases, the passive current limiting structures will be designed to limit current flow when the associated electrode terminal is in contact with a low resistance return path back to the common or return electrode. Preferred passive current limiting structures comprise (1) inductors in series with each electrode terminal and (2) capacitors in series and inductors in parallel with each electrode terminal, as described in detail hereinafter.




Active current limiting circuit structures will usually comprise a switching element to turn off current flow whenever the associated electrode terminal contacts a low (or in some instances high) impedance return path back to the common or return electrode. The switching element could be mechanical, e.g., a relay, but preferably will be solid state, e.g., a silicon controlled rectifier (SCR) or silicon controlled switch (SCS). The switch will be turned on and off by a controller which can detect the low resistance path (typically by sensing current flow above a threshold value). The controller can be implemented in hardware or software, typically being part of the power supply.




The high frequency electrosurgical power supply optionally includes a temperature controller which is connected to the temperature sensor on the electrosurgical probe and which adjusts the output voltage of the voltage source in response to a temperature set point and the measured temperature value received from the probe. In this way, the power output and temperature may be controlled while the individual current sources limit or block the power output from corresponding individual electrode terminals. Such limitation of individual electrode terminal power outputs is critical to limiting energy loss from the electrode array as described in more detail below.




The present invention still further provides an electrosurgical system including both the electrosurgical probe and electrosurgical power supply as described above.




According to the method of the present invention, an electrosurgical probe is positioned adjacent to a body structure so that an electrode array is brought into at least partial contact with the structure. The electrode array includes a plurality of isolated electrodes, and a high frequency voltage is applied between the electrode array and the patient's body. The voltage causes current flow between each electrode terminal and the body structure which is through all low electrical impedance paths is preferably but not necessarily limited. It will be appreciated that such low impedance paths generally occur when an electrode terminal does not contact the body structure, but rather is in contact with a low impedance environment, such as saline, blood, or other electrolyte. The presence of an electrolyte provides a relatively low impedance path back to the common or return electrode, which may be on the electrosurgical probe or may be attached externally to the patient. Such electrosurgical methods are particularly useful when a region is to be flushed with saline, such as in an electrosurgical ablation of fibrocartilage, articular cartilage, meniscal tissue, and the like, in arthroscopic procedures.




In some cases, it may be desirable to provide current limitation or control when individual electrode terminals contact very high resistance body structures, such as bone, cartilage (which has a higher resistivity than meniscus and other tissues), and the like. Current limitation when the electrode terminals contact high resistance structures will usually require active control schemes (i.e., passive control circuitry will be inadequate), and it will be possible to provide control protocols where current can be limited when it either exceeds or falls below an expected range characteristic of the target tissue to be treated.











A further understanding of the nature and advantages of the invention will become apparent by reference to the remaining portions of the specification and drawings.




BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a perspective view of the electrosurgical system including an electrosurgical probe and electrosurgical power supply constructed in accordance with the principle of the present invention.





FIG. 2

is an enlarged, detailed view of the distal tip of the electrosurgical probe of FIG.


1


.





FIG. 3

is a cross-sectional view of the distal tip of the electrosurgical probe of

FIGS. 1 and 2

.





FIG. 4

is a schematic view of a particular connector and lead arrangement which can be employed in the electrosurgical probe of

FIGS. 1-3

.





FIG. 5

is a detailed cross-sectional view of the distal end of an electrosurgical probe illustrating an electrode arrangement suitable for rapid cutting and ablation or tissue structures.





FIG. 6

is a detailed left-end view of the distal end of the electrosurgical probe of FIG.


5


.





FIG. 7

is a detailed cross-sectional view of the distal end of an electrosurgical probe illustrating an electrode arrangement suitable for smoothing of tissue structures.





FIG. 8

is a perspective view of an electrosurgical probe with the electrode array disposed at a right angle to the axis of shaft of probe.





FIG. 9

is a perspective view of an electrosurgical probe with electrode arrays disposed on the lateral and tip surfaces at the distal end of the probe.





FIG. 10

is a perspective view of the distal end of an electrosurgical probe with an atraumatic shield extending distally from the electrode array.





FIG. 11

illustrates use of the probe of

FIG. 10

in ablating target tissue.





FIG. 12

is a detailed end view of an electrosurgical probe having an elongate, linear array of electrode terminals suitable for use in surgical cutting.





FIG. 13

is a detailed view of a single electrode terminal having a flattened end at its distal tip.





FIG. 14

is a detailed view of a single electrode terminal having a pointed end at its distal tip.





FIG. 15

is a detailed view of a single electrode terminal having a square end at its distal tip.





FIGS. 16 and 16A

are electrical schematic diagrams illustrating two embodiments or the circuitry of a high frequency power supply constructed in accordance with the principles of the present invention.





FIG. 17

is a perspective view of the distal end of an electrosurgical probe having an elongate, linear array of electrode terminals.





FIG. 18

is a perspective view of the distal end of an electrosurgical probe having a deflectable distal tip.











DESCRIPTION OF THE PREFERRED EMBODIMENT




The present invention provides a method and apparatus for selectively heating a target location within a patient's body, such as solid tissue or the like, particularly including articular cartilage, fibrocartilage, meniscal tissue, and the like. In addition to articular cartilage and fibrocartilage, tissues which may be treated by the method and apparatus of the present invention include tumors, abnormal tissues, and the like. For convenience, the remaining disclosure will be directed specifically at the cutting, shaping or ablation of fibrocartilage and articular cartilage during arthroscopic or endoscopic procedures but it will be appreciated that the apparatus and methods can be applied equally well to procedures involving other tissues of the body, as well as to other procedures including open surgery, laparoscopic surgery, thoracoscopic surgery, and other endoscopic surgical procedures.




The target tissue will be, by way of example but not limited to, articular cartilage, fibrocartilage, and meniscal tissue, such as found in the joints of the knee, shoulder, hip, foot, hand and spine. The present invention uses an electrode array including a plurality of independently current-limited and/or power-controlled electrode terminals distributed over a distal contact surface of a probe to apply heat selectively to the target tissue while limiting the unwanted heating of the surrounding tissue and environment resulting from power dissipation into surrounding electrically conductive liquids, such as blood, normal saline, and the like.




The electrosurgical probe will comprise a shaft having a proximal end and a distal end which supports an electrode array near its distal end. The shaft may assume a wide variety of configurations, with the primary purpose being to mechanically support the electrode array and permit the treating physician to manipulate the array from a proximal end of the shaft. Usually, the shaft will be a narrow diameter rod or tube, more usually having dimensions which permit it to be introduced through an associated trocar or cannula in a minimally invasive procedure, such as arthroscopic, laparoscopic, thoracoscopic, and other endoscopic procedures. Thus, the shaft will typically have a length of at least 10 cm, more typically being 25 cm, or longer, and will have a diameter of at least 1 mm, usually being at least 2 mm, and frequently being in the range from 2 to 10 mm. The shaft may be rigid or flexible, with flexible shafts optionally being combined with a generally rigid external tube for mechanical support. Flexible shafts may be combined with pull wires, shape memory actuators, and other known mechanisms for effecting selective deflection of the distal end of the shaft to facilitate positioning of the electrode array. The shaft will usually include a plurality of wires or other conductive elements running axially therethrough to permit connection of the electrode array to a connector at the proximal end of the shaft. Specific shaft designs will be described in detail in connection with the figures hereinafter.




The electrode array have an area in the range from 0.01 mm


2


to 2.5 cm


2


, preferably from 0.025 mm


2


to 1 cm


2


, more preferably from 0.25 mm


2


to 50 mm


2


, and often from 0.5 mm


2


to 25 mm


2


, and will usually include at least two isolated electrode terminals, more usually at least four electrode terminals, preferably at least six electrode terminals, more preferably at least eight electrode terminals, even more preferably at least 15 electrode terminals, and still more preferably at least 20 electrode terminals, and often 50 or more electrode terminals, disposed over the distal contact surfaces on the shaft. By contacting the electrode array(s) on the contact surface(s) against target tissue and applying high frequency voltage between the array(s) and an additional common or return electrode in direct or indirect contact with the patient's body, the target tissue is selectively ablated or cut, permitting selective removal of portions of the target tissue while desirably minimizing the depth of necrosis to surrounding tissue. In particular, this invention provides a method and apparatus for effectively ablating and cutting articular cartilage and fibrocartilage by simultaneously applying both (1) electrical energy to the target tissue surrounding and immediately adjacent to the tip of the probe and (2) pressure against the target tissue using the probe itself.




Each individual electrode terminal in the electrode array is electrically insulated from all other electrode terminals in the array within said probe and is connected to a power source which is isolated from each of the other electrodes in the array or to circuitry which limits or interrupts current flow to the electrode when low resistivity material (e.g., blood or electrically conductive saline irrigant) causes a lower impedance path between the common electrode and the individual electrode terminal. The isolated power sources for each individual electrode may be separate power supply circuits having internal impedance characteristics which limit power to the associated electrode terminal when a low impedance return path is encountered or may be a single power source which is connected to each of the electrodes through independently actuable switches.




The tip region of the probe is thus composed of many independent electrode terminals designed to deliver electrical energy in the vicinity of the tip. The selective heating of the target tissue is achieved by connecting each individual electrode terminal and the common electrode (e.g., a band of conductive material proximal to the electrode array at the tip or an external electrode which is placed on the outside of the patient's body) to a power source having independently controlled or current-limited channels The application of high frequency voltage between the common electrode and the electrode array results in the conduction of high frequency current from each individual electrode terminal to the said common electrode. The current flow from each individual electrode terminal to the common electrode is controlled by either active or passive means, or a combination thereof, to deliver electrical energy to the target tissue while minimizing energy delivery to surrounding (non-target) tissue and any conductive fluids which may be present (e.g., blood, electrolytic irrigants such as saline, and the like).




In a preferred aspect, this invention takes advantage of the differences in electrical resistivity between the target tissue (e.g., articular cartilage or fibrocartilage) and the surrounding conductive liquid (e.g., isotonic (normal) saline irrigant). By way of example, for any selected level of applied voltage, if the electrical conduction path between the common electrode and one of the individual electrode terminals within the electrode array is isotonic saline irrigant liquid (having a relatively low electrical resistivity), said current control means connected to the individual electrode will limit current flow so that the heating of intervening conductive liquid is minimized. In contrast, if a portion of or all of the electrical conduction path between the common electrode and one of the individual electrode terminals within the electrode array is articular cartilage or fibrocartilage (having a relatively higher electrical resistivity), said current control circuitry or switch connected to said individual electrode will allow current flow sufficient for the heating or ablation or electrical breakdown of the target tissue in the immediate vicinity of the electrode surface.




The application of a high frequency voltage between the common or return electrode and the electrode array for appropriate time intervals effects ablation, cutting or reshaping of the target tissue. The tissue volume over which energy is dissipated (i.e., a high voltage gradient exists) may be precisely controlled, for example, by the use of a multiplicity of small electrodes whose effective widths (i.e., diameters for round wire terminals) range from about 0.05 mm to 2 mm, preferably from about 0.1 mm to 1 mm. Electrode terminal areas for both circular and non-circular terminals will have a contact area below 5 mm


2


, preferably being in the range from 0.001 mm


2


to 2 mm


2


, and more preferably from 0.01 mm


2


to 1 mm


2


. The use of small electrode terminals reduces the extent and depth of tissue necrosis as a consequence of the divergence of current flux lines which emanate from the exposed surface of each electrode terminal. Energy deposition in tissue sufficient for irreversible damage (i.e., necrosis) has been found to be limited to a distance of about one-half to one electrode terminal diameter. This is a particular advantage over prior electrosurgical probes employing single and/or larger electrodes where the depth of tissue necrosis may not be sufficiently limited. Heretofore, increased power application and ablation rates would usually be achieved by increasing the electrode area. Surprisingly, with the present invention, it has been found that the total electrode area can be increased (to increase power delivery and ablation rate) without increasing depth of necrosis by providing multiple small electrode terminals. Preferably, the terminals will be spaced-apart by a distance in the range from one-tenth diameter to one diameter for optimum power delivery, with smaller spacing between larger terminals. The depth of necrosis may be further controlled by switching the applied voltage off and on to produce pulses of current, said pulses being of sufficient duration and associated energy density to effect ablation and/or cutting while being turned off for periods sufficiently long to allow for thermal relaxation between energy pulses. In this manner, the energy pulse duration, magnitude and the time interval between energy pulses are selected to achieve efficient rates of tissue ablation or cutting while allowing the temperature of the heated zone of tissue to “relax” or return to normal physiological temperatures before the onset of the next energy (current) pulse.




The rate of energy delivery to the target tissue is controlled by the applied voltage level and duty cycle of the voltage pulse. The use of high frequency current minimizes induced stimulation of muscle tissue or nerve tissue in the vicinity of the body structure being treated. In addition, high frequency minimize the risk of interfering with the natural pacing of the heart circumstances where the probe of the present invention is used near the heart.




The power applied to the common electrode and the electrode array will be at high or radio frequency, typically between about 20 kHz and 20 MHz, usually being between about 30 kHz and 1 MHz, and preferably being between about 50 kHz and 400 kHz. The RMS (root mean square) voltage applied will usually be in the range from about 5 volts to 1000 volts, preferably being in the range from about 50 volts to 800 volts, and more preferably being in the range from about 10 volts to 500 volts. Usually, the current level will be selectively limited or controlled and the voltage applied will be independently adjustable, frequently in response to the resistance of tissues and/or fluids in the pathway between an individual electrode and the common electrode. Also, the applied current level may be in response to a temperature control means which maintains the target tissue temperature with desired limits at the interface between the electrode arrays and the target tissue. The desired surface temperature of the target tissue will usually be in the range from about 40° C. to 500° C., and more usually from about 50° C. to 300° C.




The preferred power source of the present invention delivers a high frequency current selectable to generate average power levels ranging from tens of milliwatts to tens of watts per electrode, depending on the target tissue being heated, the rate of ablation desired or the maximum allowed temperature selected for the probe tip. The power source allows the user to select the current level according to the specific requirements of a particular arthroscopy procedure or other endoscopic procedure.




The power source will be current limited or otherwise controlled so that undesired heating of electrically conductive fluids or other low electrical resistance tissues does not occur. In a presently preferred embodiment of the present invention, current limiting inductors are placed in series with each independent electrode terminal, where the inductance of the inductor is selected to provide high impedance at the frequency of operation. Alternatively, capacitor-inductor (LC) circuit structures may be employed, as described in more detail below. Additionally, a current limiting resistor may be selected having a large positive temperature coefficient of resistance so that, as the current level begins to rise for any individual electrode in contact with a low resistance medium (e.g., saline irrigant), the resistance of the current limiting resistor increases significantly, thereby minimizing the power delivery from said electrode into the low resistance medium (e.g., saline irrigant). Thus, the electrode terminal sees a relatively constant current source so that power dissipation through a low resistance path, e.g., normal saline irrigant, will be substantially diminished.




As an alternative to such passive circuit structures, constant current flow to each electrode terminal may be provided by a multi-channel power supply. A substantially constant current level for each individual electrode terminal within a range which will limit power delivery through a low resistance path, e.g., isotonic saline irrigant, would be selected by the user to achieve the desired rate of cutting or ablation. Such a multi-channel power supply thus provides a constant current source with selectable current level in series with each electrode terminal, wherein all electrodes will operate at or below the same, user selectable maximum current level. Current flow to all electrode terminals could be periodically sensed and stopped if the temperature measured at the surface of the electrode array exceeds user selected limits. Particular control system designs for implementing this strategy are well within the skill of the art.




Yet another alternative involves the use of one or several power supplies which allow one or several electrodes to be simultaneously energized and which include active control means for limiting current levels below a preselected maximum level. In this arrangement, only one or several electrodes would be simultaneously energized for a brief period. Switching means would allow the next one or several electrodes to be energize for a brief period. By sequentially energizing one or several electrodes, the interaction between adjacent electrodes can be minimized (for the case of energizing several electrode positioned at the maximum possible spacing within the overall envelope of the electrode array) or eliminated (for the case of energizing only a single electrode at any one time). As before, a resistance measurement means may be employed for each electrode prior to the application of power wherein a (measured) low resistance (below some preselected level) will prevent that electrode from being energized during given cycle. By way of example, the sequential powering and control scheme of the present invention would function in a manner similar to an automobile distributor. In this example, an electrical contact rotates past terminals connected to each spark plug. In this example, each spark plug corresponds to the exposed surface of each of the electrodes. In addition, the present invention includes the means to measure the resistance of the medium in contact with each electrode and cause voltage to be applied only if the resistance exceeds a preselected level.




The electrode array is formed over a contact surface on the shaft of the electrosurgical probe. The area of the contact surface can vary widely, and the contact surface can assume a variety of geometries, with particular areas in geometries being selected for specific applications. Electrode array contact surfaces will have areas as set forth above and can be planar, concave, convex, hemispherical, conical, or virtually any other regular or irregular shape. Most commonly, the electrode arrays will be formed at the distal tip of the electrosurgical probe shaft, frequently being planar, disk-shaped, or hemispherical surfaces for use in reshaping procedures or being linear arrays for use in cutting. Alternatively or additionally, the electrode arrays may be formed on lateral surfaces of the electrosurgical probe shaft (e.g., in the manner of a spatula), facilitating access to certain body structures in electrosurgical procedures.




In an exemplary embodiment as shown in

FIG. 1

, a probe


10


includes an elongated shaft


13


which may be flexible or rigid, with flexible shafts optionally being disposed with support cannulas or other structures (not shown). Referring to

FIGS. 1 and 2

, the probe


10


includes an array of electrode terminals


58


disposed on the distal tip


12


of shaft


13


. The electrode terminals


58


are electrically isolated from each other and from a common or return electrode


17


which is disposed on the shaft proximally of the electrode array, preferably being with 1 mm to 25 mm of the distal tip


12


. Proximally from the tip


12


, the return electrode


17


is generally concentric with the shaft of the probe


10


. Said probe


10


may be constructed having zones of varying flexibility (or conversely, stiffness) along the probe length. It is advantageous, for example, to have greater flexibility (i.e., lesser stiffness) at the distal end of the probe


10


(region L


3


in.

FIG. 1

) in order to increase the capability of the probe to gain access to operative sites which are not in a direct line path with the entrance site into the body cavity. In the preferred embodiment illustrated in

FIG. 1

, probe


10


would have two or three regions wherein regions L


1


and L


2


are stiffer than region L


3


. The preferred length for region L


1


is in the range from 0.5 mm to 25 mm, for region L


2


is in the range from 1 mm to 20 mm, and for region L


3


is from 5 cm to 25 cm.




Still referring to

FIGS. 1 and 2

, each of the terminals


58


is connected to an active or passive control network within a power source and controller


28


by means of the individually insulated conductors


42


. The proximal portion of the probe


10


is also equipped with a connector


19


which can be removably connected to a connector


20


in a reusable handle


22


. The proximal portion of the handle


22


and cable


24


also has a connector


26


for providing the electrical connections to the controller


28


.




Referring to

FIG. 1

, the power source and controller


28


provides high frequency voltage to the electrode terminals


28


(of

FIG. 2

) by means of a cable


24


from connector


20


in handle


22


to receptacle


26


, the power source and controller


28


. The power source and controller


28


has a selector


30


to change the applied voltage level. A conductor


44


extends from the common electrode


17


(

FIG. 2

) and is connected to the power source and controller


28


by the same cable


24


. The power source and controller


28


also includes the means for energizing the electrodes


58


of probe


10


through the depression of foot pedal


39


in a foot pedal


37


Positioned close to the user. The assembly


37


may also include a second pedal not shown) for remotely adjusting the energy level applied to electrodes


58


.




Referring to FIG.


2


and

FIG. 3

, the distal tip


12


of probe


10


in the preferred embodiment contains the exposed surfaces of the electrode terminals


58


. The electrode terminals


58


are secured in a matrix


48


of suitable insulating material (e.g., ceramic or glass) which could be formed at time of manufacture in a flat, hemispherical or other shape according to the requirements of a particular procedure. Proximal to the distal tip


12


, the isolated electrode wires


42


are contained in an insulating insert


14


(

FIG. 3

) of generally cylindrical shape extending from matrix


48


and into a tubular support member


56


.




Referring to

FIGS. 2 and 3

, the tubular support member


56


is preferably formed from an electrically conductive material, usually metal, and is disposed within an electrically insulative jacket


18


. The electrically conductive tubular support member


56


defines the common or return electrode


17


with respect to the array of individual electrodes


12


in order to complete the electrical circuit such that current will flow between each individual electrode


58


and the common electrode structure


17


. The common electrode


17


is located near the distal tip


12


of probe


10


. The insulating insert


14


distal to the common electrode


17


is composed of an electrically insulating material such as epoxy, plastic, ceramic, glass or the like. The electrically conductive tubular support member


56


will preferably be sufficiently rigid to provide adequate column strength to manipulate body structures with the shaft of probe


10


. The tubular member


56


is composed of a material selected from the group consisting of stainless, titanium or its alloys, molybdenum or its alloys, and nickel or its alloys. The electrically conductive tubular member


56


will preferably be composed of the same metal or alloy which forms the electrode terminals


58


to minimize any potential for corrosion or the generation off electrochemical potentials due to the presence of dissimilar metals contained within an electrically conductive fluid


50


such as isotonic saline commonly used as an irrigant for the intended applications.




Referring now to

FIGS. 2 and 3

, the common electrode terminal structure


17


includes a perforate shield


16


formed from an electrically insulating material which is porous or which contains openings which allow a surrounding electrically conducting liquid


50


(e.g., isotonic saline) to contact the electrically conductive layer


54


which is electrically coupled to the tubular member


56


. As shown in

FIG. 3

, an annular gap


54


may be provided between electrically insulating member


16


and common electrode member


56


. Proximal to the common electrode region


17


, the tubular member


56


is covered over its entire circumference by the electrically insulating jacket


18


, which is typically formed as one or more electrically insulative sheaths or coatings, such as polytetrafluoroethylene, polyimide, and the like. The annular gap


54


preferably has capillary dimensions to maximize fluid contact even when the common electrode terminal structure


17


is not fully immersed in the electrically conductive liquid.




The provision of the electrically insulative jacket


16


over the common electrode structure


17


prevents direct electrical contact between the surface of tubular member


56


and any adjacent body structure. Such direct electrical contact between a body structure (e.g., tendon) and an exposed common electrode member


56


could result in unwanted heating and necrosis of the structure at the point of contact. As shown in

FIG. 3

, any contact between the common electrode structure


17


(including perforate shield


16


) and a body structure will only result in the passage of relatively low current density flux lines


60


, thereby minimizing the Joulean heating which could occur in any adjacent body structure. Referring to

FIGS. 1 and 3

, electrical communication between tubular member


56


and the connector


19


may be provided by an electrically conducting lead wire


44


.




The electrode terminals


58


are electrically insulated from each other and are secured together in an array by the electrically insulating matrix


48


. The insulating matrix


48


may be ceramic, glass or other high-temperature insulating material. Proximal to the distal tip


12


, the electrode wires


42


are covered with an electrically insulating material (e.g., polyimide) and are contained in tubular member


56


which extends the length of the probe


10


. The distal tip


12


end of the probe


10


includes the common electrode structure


17


extending over a length L


2


which may range from 1 to 20 mm, preferably being from 2 mm to 20 mm. A tip offset L


1


provides a minimum separation between said common electrode


17


and the array of electrodes


12


, usually being at least 0.5 mm, more usually being at least 1 mm, and sometimes being 2 mm or greater, and preferably being in the range from 0.5 mm to 2 mm.




A central aspect of the present invention is the ability of the probe


10


to deliver high energy flux levels selectively only to the intended areas, i.e., the target tissue T, and not to surrounding healthy tissue or electrically conducting fluids (e.g., isotonic saline irrigant). Such directed energy transfer results in selective heating of the target tissue which allows the probe to cut, ablate or recontour the target tissue. Referring to

FIGS. 2 and 3

, when the electrode array


12


of the probe


10


is engaged against a region of target tissue


52


, some of the electrode terminals


58


will be in contact with target tissue, while other electrode terminals may be in contact with electrically conducting fluid


50


. Each of the electrode terminals


58


experiences an electrical impedance which is characteristic of the material which is disposed between the individual electrode terminals


58


and the common electrode structure


17


. The present invention takes advantage of the fact that the electrical impedance (resistivity) of typical target tissue at frequencies of 50 kHz or greater (e.g., fibrocartilage and articular cartilage) is higher by a factor of approximately four or more than that of the surrounding electrically conducting fluid


50


typically used as an irrigant during arthroscopic and endoscopic procedures. Thus, if the current passing through each of the electrode terminals


58


is limited to a preselected maximum value, the regions of higher electrical resistance will generate more Joulean heating (power=I


2


R, where I is the current through resistance, R) than a region of lower electrical resistance.




In contrast to the present invention, electrosurgical methods and apparatus of the prior art involving a single electrode exhibit substantially reduced effectiveness when a portion of the exposed electrode is in contact with a low-resistance pathway (e.g., isotonic saline irrigant). In those circumstances, the majority of power delivered from the single electrode tip is dissipated within the low resistance electrically conducting fluid, thereby significantly reducing the capability to cut or ablate the target tissue.




Furthermore in accordance with the teachings of the present invention, temperature measurement means may be provided in the distal tip


12


to limit the power delivery if measured temperatures exceed user selected levels. Therefore, by either one or a combination of both means described above the target tissue will be selectively heated up while the conductive liquids will experience a minimal rise in temperature. Thus, the probe


10


will selectively and efficiently cut or ablate the target tissue.




Still referring to

FIG. 3

, another aspect of the present invention is the restriction of high current densities or fluxes to a confined region


62


as defined by the current flux lines


60


. The confinement of the high current densities to a limited region


62


allows healthy tissue nearby to remain at or near normal physiologic temperatures, thereby limiting the depth of necrosis into surrounding or underlying healthy tissue


52


to a depth of approximately one electrode diameter.




Alternatively, by energizing only one or several electrode terminals


58


at any one time, the depth of necrosis can be still further reduced since the thermal relaxation time between energy pulses for any specific electrode will serve to further limit the depth of necrosis.




Referring to

FIGS. 1 and 4

, the proximal end of probe


10


includes a connector


19


which includes a multiplicity of electrically conductive pins or contacting member


74


which are in electrical communication with each electrode wire


42


. Said electrical communication may be accomplished through mechanical crimping of the terminus of connector pin


74


onto the bare (exposed) electrode lead wire


42


at location


80


. Alternatively, the electrode lead wire may be welded, brazed or soldered to the connector pin


74


at location


80


. Likewise, the return wire


44


electrically communicating with the common electrode member


56


is connected to one connector pin


76


in a like manner as described above for the electrode leads.




The multiplicity of connector pins


74


and


76


are maintained in a predetermined spaced-apart relationship which corresponds to a mating receptacle


20


at the distal end of the handle


22


. The position of the contact pins


74


and


76


is maintained by an electrically insulative member


78


which is secured within a connector housing


72


using adhesives, ultrasonic welding or the like. Alternatively, the connector housing may be overmolded around the connector pin assembly


78


and proximal end of the probe shaft member. In the embodiment shown in

FIG. 4

, the electrically conductive tubular member


56


is inserted into the distal end of the connector


72


and secured using an adhesive or potting material (e.g., epoxy). The electrically insulative jacket


18


extends from the proximal edge of the common electrode structure


17


to and over an extension


73


at the distal end of the connector housing


72


. The electrically insulating jacket


18


thereby effects a liquid tight seal at an interface


82


between the jacket


18


and the connector extension


73


. The seal prevents the leakage of electrically conductive liquid (e.g., isotonic saline) into the cavity containing the electrical leads and connector pins which could result in an electrical short between the electrodes and/or between any electrode and the common electrode


17


.




Still referring to

FIG. 4

, a sealing means


84


may also be provided at the proximal end or the connector housing


72


in order to minimize the leakage of electrically conductive liquid (e.g., isotonic saline) at the interface between the connector


19


and the handle connector


20


. Said seal member


84


may include a conventional elastomeric o-ring placed in a suitably sized o-ring groove within the connector housing


72


.




Referring to

FIGS. 5 and 6

, an embodiment of the present invention designed for rapid ablation of body structures includes a circular array


12


of electrode terminals


58


maintained in a spaced-apart relationship by electrical insulating matrix


48


. For convenience, identical numbering for similar elements will be used for all embodiments. Said electrode terminals


58


may be fabricated using wires having diameters in the preferred range set forth above with an electrically insulating coating extending up to or through the electrically insulating member


48


. The regions of the electrode terminals


58


distal to the distal face of the electrically insulating matrix


48


are bare (i.e., no electrically insulating coating) so that the electrode terminals


58


are directly exposed to the surrounding electrically conductive liquid (e.g., isotonic saline) or body structure. The wires and electrode terminals


58


will usually be metals or metal alloys, preferably being selected from the group comprising titanium, tantalum, molybedeum, tungsten, platinum, rhodium, and alloys thereof. The wires and electrode terminals


58


may be solid or may be composites including a core wire which has been coated with one or more of the above metals, compounds or alloys thereof. The electrically insulative matrix


48


may be ceramic or glass or glass/ceramic composition (e.g., alumina, borosilicate glass, quartz glass, or the like).




Still referring to

FIGS. 5 and 6

, the electrode terminals


58


may extend a distance X


3


beyond the distal face of the electrically insulating matrix


48


, forming protrusions. The extension length X


3


may range from 0.05 to 1.0 mm, more preferably being in the range from 0.1 mm to 0.4 mm. The interelectrode spacing X


1


ranges from 0.07 mm to 0.4 mm. The electrode terminals


58


may be circular, square, rectangular, triangular or polygonal, or irregular in cross-sectional shape. The characteristic dimension D


1


(i.e., diameter in the case of circular electrodes shown in

FIG. 6

) ranges from 0.1 mm to 0.5 mm depending on the overall size of the probe, the rate of ablation required and the maximum allowed depth of necrosis of the body structure being treated. The overall diameter D


2


of the electrode array


12


may range from 0.5 mm to 10 mm, more preferably 1 mm to 5 mm, depending on the particular application and size of the body structure to be treated. In the case of the circular electrode array


12


shown in

FIG. 6

, the electrode terminals


58


are positioned a small distance X


2


from the perimeter of the electrically insulating matrix


48


. Said distance X


2


is preferably maintained as small as practical to maximize the zone of body structure ablated so that it approximates the diameter D


2


of the distal end of the probe


10


, thereby permitting the probe to readily engage the body structure to be ablated without mechanical resistance resulting from an excessive border or distance X


2


where no ablation has occurred. The distance X


2


is preferable less than 0.5 mm and more preferably less than 0.3 mm.




Referring to

FIG. 7

another embodiment of the present invention intended for smoothing of body structures (e.g., articular cartilage located on the surface of a condyle) while minimizing the depth of necrosis of the underlying tissue includes electrode terminals


58


in an electrical insulating matrix


48


is similar to the array shown in

FIGS. 5 and 6

except that the electrode terminals


58


are flush with the surface of the electrically insulating matrix


48


. The rate of ablation achievable with the use of “flush” electrode terminals


58


is lower than that for electrodes which extend beyond the face of the electrically insulative matrix


48


, but such flush electrode structure can provide a smoother surface on the body structure being treated while minimizing the depth of ablation and necrosis.




Referring to

FIG. 3

, an alternative configuration of the shaft of a probe


100


is illustrated. This configuration is similar to the electrode array on distal tip


12


of probe


10


and shaft


14


arrangement shown in

FIGS. 5 and 7

, except that the shaft


14


near the distal end of probe


100


is bent at an angle with respect to the longitudinal axis of the probe. Said angle may range from about 15 degrees to 90 degrees or more depending on the particular tissue structure to be treated. By way of example, the electrode terminal


58


arrangement shown in

FIG. 8

allows the electrode array to move over a body structure disposed parallel to the longitudinal axis of the probe


100


with said movement corresponding to forward and backward motion of the probe handle


22


. Said electrode terminals


58


may extend beyond the surface of the electrically insulating matrix


48


as shown in

FIGS. 5 and 8

or may be flush with the electrically insulating matrix


48


as shown in FIG.


7


.




Yet another embodiment of the electrode array of the present invention is illustrated in

FIG. 9

, wherein electrode terminals


58


are disposed on two (or more) surfaces of the distal end of a probe


120


. By way of example, electrode terminals


58




a


may be located on a lateral surface, spaced-apart by an electrically insulative matrix


48




a


, and electrodes


58




b


may be located on the distal tip of the probe


120


, spaced-apart by an electrically insulating matrix


48




b


. The two electrode arrays are supported by an electrically insulating member


82


preferably having rounded atraumatic edges


80


to prevent any unwanted mechanical damage (e.g., abrasion) to the tissue being treated. As described in the previous embodiments, a common electrode structure


17


is disposed proximal to these electrode arrays to provide for the return electrical current path.




Yet another embodiment of the present invention is illustrated in

FIGS. 10 and 11

. In this embodiment, an electrically insulating shield


74


(or member with electrically insulative coating) extends beyond an array of electrode terminals


58


having a width, length and thickness suitable to allow the electrode terminals


58


at the tip of probe


140


to engage a body structure


52


(e.g., meniscus) while preventing any current flow and related damage to another closely position body structure


92


(e.g., the nearby articular cartilage


92


located on the surface of the condyle


90


). In this manner, the array of electrode terminal


58


can be brought into close contact with the target tissue


52


without endangering any critical body structures nearby. By way of example, shield


74


may be a metal tab or extension from the crone body which is covered or coated with electrical insulation. Alternatively, the spatula shaped member


74


may be formed by injection molding as an integral portion of the insulating insert


14


.




Yet another embodiment is illustrated in FIG.


12


and is designed for cutting of body structures. In this embodiment, the electrode terminals


58


are arranged in a linear or columnar array of one of more closely spaced columns so that as the electrodes


58


are moved along the longer axis (denoted by arrow


160


in FIG.


12


), the current flux lines are narrowly confined at the tip of the electrode terminals


58


and result in a cutting effect in the body structure being treated. As before, the current flux lines


60


emanating from the electrode terminals


58


pass through the electrically conducting liquid to the common electrode structure


17


located proximal to the probe tip.




Referring now to

FIGS. 13

,


14


and


15


, several alternative geometries are shown for the electrode terminals


58


. These alternative electrode geometries allow the electrical current densities emanating from the electrode terminals


58


to be concentrated to achieve an increased ablation rate and/or a more concentrated ablation effect due to the fact that sharper edges (i.e. regions of smaller radii of curvature) result in higher current densities.

FIG. 13

illustrates a flattened extension of a round wire electrode terminal


58


which results in higher current densities at the edges


180


. Another example is shown in

FIG. 14

in which the electrode terminal


58


is formed into a cone shaped point


182


resulting in higher current densities at the tip of the cone. Yet another example is shown in

FIG. 15

in which the electrode


58


is a square wire rather than a round wire. The use of a square wire results in high current densities along each edge


184


which results from the juncture of adjacent faces.




Referring to

FIG. 16

, a high frequency power supply


28


comprises a voltage source


98


which is connected to a multiplicity of current limiting elements


96




a


,


96




b


, . . . ,


96




z


, typically being inductors having an inductance in the range from 100 to 5000 microhenries, with the particular value depending on the electrode terminal dimensions, the desired ablation rates, and the like. In the case of ablation of articular and fibrocartilage, suitable inductances will usually be in the range from 50 to 5000 microhenries. Capacitors having capacitance values in the range from 200 to 10,000 picofarads may also be used as the current limiting elements.




Current limiting elements may also be part of a resonant circuit structure having a capacitor


101


in series with the electrode terminal and an inductor


103


between the electrode lead and the common lead, as illustrated in FIG.


16


A. The inductor and capacitor values are selected according to the operating frequency of the voltage source


98


. By way of example, at an operating frequency of 100 kHz, current limiting circuit structures may incorporate inductor/capacitor combinations such as (1) 2530 microhenries and 1000 picofarads; (2) 5390 microhenries and 470 picofarads; or (3) 11,400 microhenries and 220 picofarads, respectively.




It would also be possible to use resistors as the current limiting elements. The use of resistors, however, is generally less preferred than use of inductors or capacitor/inductor tuned circuit structures since resistors will have significant IR


2


power losses which are generally avoided with the circuits of

FIGS. 16 and 16A

.




Referring to

FIGS. 1

,


16


, and


16


A, each of the individual leads


97


from the current limiting elements


96


and


101


/


103


are removably connected to leads


92


in cable


24


via connector


26


. A common electrode lead


99


from voltage source


98


is removably connected to lead


94


in cable


24


via the same connector


26


. Each of the electrode leads


92


and common electrode lead


94


in cable


24


extend into and through handle


22


and terminate in connector


20


located at the distal end of handle


22


. As described with reference to

FIGS. 3 and 4

, electrical leads


92


and common electrode lead


94


connect to electrode leads


42


and common electrode lead


44


, respectively, via the interface between removably attachable connectors


19


and


20


. In this manner, each of the electrodes in array


12


can be powered by a single voltage source


98


with independent current limiting elements or circuit structures attached to each electrode lead


42


via cable lead


92


and controller lead


96


.




Current limitation could alternatively be accomplished by providing a separate power supply and current measuring circuitry for each electrode terminal. Current flow to any electrode terminal which exceeds a preselected (or adjustable) limit would be decreased or interrupted.




Another embodiment of the probe of the present invention intended for cutting or ablation of body structures surrounded by electrically conducting liquid (i.e., isotonic saline irrigant) is shown in FIG.


17


. Two pairs of electrode terminals


58




a


/


59




a


and


58




b


/


59




b


having flattened tips are shown. Leads


58




a


and


58




b


are electrically insulated from each other and are individually connected to a separate power source or common voltage supply with independent current limiting circuitry, as discussed above. If an independent power source is used for each pair, then current flow between the electrodes in pair


58




a


and


59




a


as well as between the electrodes in pair


58




b


and


59




b


. If the leads


44




a


and


44




b


from electrodes


59




a


and


59




b


are connected to a common electrode


99


in power supply


28


, then current will flow between electrode terminals


58




a


/


58




b


and electrodes


59




a


/


59




b


. In particular, current will also flow between electrode


58




b


and


59




a


. The linear arrangement of electrodes in

FIG. 17

is particularly well-suited to rapid cutting of body structures while restricting current flux lines


60


to the near vicinity of the tip of the probe.




Another embodiment of the probe of the present invention is illustrated in FIG.


18


. The probe


200


contains a flexible distal region


112


which can be deflected relative to a longitudinal axis


114


. Such deflection may be selectively induced by mechanical tension, by way of example, through axial translation of thumb slide


108


located on handle


22


which, in turn, increases or decreases tension on a radially offset pull wire


110


connected between the slide and the distal end of the probe


200


. Alternatively, a shape memory wire may be used which expands or contracts in response to temperature changes in the wire induced by externally applied heating currents. Thumb slide


108


could be connected to a rheostat (not shown) which would control a heating current through the wire


110


, causing the wire to expand or contract depending on the level of the applied current. Said controllable deflection means improves access to body structures in certain surgical situations.




Although the foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.



Claims
  • 1. An electrosurgical instrument for applying electrical energy to a tissue structure at a target site, the probe comprising:a shaft having a proximal end a distal end, where the distal end has a contact surface; an active electrode secured to the shaft and having an exposed portion extending from the distal end of the shaft, such that the exposed portion forms a protrusion on the distal end contact surface; a return electrode coupled to the shaft and having an exposed fluid contact surface where the return electrode is located circumferentially about the shaft and has a substantially greater surface area than the active electrode; at least one connector disposed near the proximal end of the shaft for electrically coupling the active and return electrodes to a high frequency voltage source; and wherein the exposed fluid contact surface of the return electrode is axially spaced from the exposed portion of the active electrode by a distance of at least 1 mm.
  • 2. The instrument of claim 1 wherein the exposed fluid contact surface of the return electrode is axially spaced from the exposed portion of the active electrode by a distance of about 1 to 2 mm.
  • 3. The instrument of claim 1 wherein the exposed fluid contact surface of the return electrode is axially spaced from the exposed portion of the active electrode by a distance of about 1.0 to 5.0 mm.
  • 4. The instrument of claim 1 wherein the return electrode has an exposed surface area at least 5 times greater than an exposed surface area of the active electrode.
  • 5. The instrument of claim 1 wherein the active electrode comprises a single active electrode disposed near the distal end of the shaft.
  • 6. The instrument of claim 1 wherein the active electrode includes an array of electrically isolated active electrodes disposed near the distal end of the shaft forming a plurality of protrusions on the distal end contact surface.
  • 7. The instrument of claim 6 further comprising a plurality of current limiting elements for controlling current flow from at least two of the active electrodes based on electrical impedance between each active electrode and the return electrode.
  • 8. The instrument of claim 1 wherein the return electrode is spaced from the active electrode by an electrically insulating member comprising an inorganic material.
  • 9. The method of claim 8 wherein the inorganic material is selected from the group consisting essentially of ceramic, glass and glass/ceramic compositions.
  • 10. The instrument of claim 1 wherein the active electrode and the return electrode are configured to effect the electrical breakdown of tissue in the immediate vicinity of the active electrode when high frequency voltage is applied between the active electrode and the return electrode in the presence of electrically conducting fluid.
  • 11. The instrument of claim 1 wherein the exposed fluid contact surface of the return electrode is axially spaced from the exposed portion of the active electrode by a distance of at least 2 mm.
Parent Case Info

This application is a division of and claims the benefit of U.S. application No. 09/258,516/Feb. 26, 1999 now abandoned which is a division of 08/761,096/Dec. 5, 1996 now U.S. Pat. No. 6,312 408, which is division of 08/446,767/Jun. 2, 1995 now U.S. Pat. No. 5,697,909, which is a continuation-in-part 08/059,681/May 10, 1993, now abandoned, the disclosure of which is incorporated by referenced.

US Referenced Citations (231)
Number Name Date Kind
2050904 Trice Aug 1936 A
3815604 O'Malley et al. Jun 1974 A
3920021 Hiltebrant Nov 1975 A
4033351 Hetzel Jul 1977 A
4040426 Morrison, Jr. Aug 1977 A
4043342 Morrison, Jr. Aug 1977 A
4116198 Roos Sep 1978 A
4184492 Meinke et al. Jan 1980 A
4202337 Hren et al. May 1980 A
4228800 Degler, Jr. et al. Oct 1980 A
4232676 Herczog Nov 1980 A
4240441 Khalil Dec 1980 A
4248231 Herczog et al. Feb 1981 A
4326529 Doss et al. Apr 1982 A
4381007 Doss Apr 1983 A
4476862 Pao Oct 1984 A
4483338 Bloom et al. Nov 1984 A
4532924 Auth et al. Aug 1985 A
4548207 Reimels Oct 1985 A
4567890 Ohta et al. Feb 1986 A
4590934 Malis et al. May 1986 A
4593691 Lindstrom et al. Jun 1986 A
4658817 Hardy Apr 1987 A
4674499 Pao Jun 1987 A
4682596 Bales et al. Jul 1987 A
4706667 Roos Nov 1987 A
4709698 Johnston et al. Dec 1987 A
4727874 Bowers et al. Mar 1988 A
4736743 Daikuzono Apr 1988 A
4737678 Hasegawa Apr 1988 A
4762128 Rosenbluth Aug 1988 A
4765331 Petruzzi et al. Aug 1988 A
4785806 Deckelbaum Nov 1988 A
4785823 Eggers et al. Nov 1988 A
4805616 Pao Feb 1989 A
4813429 Eshel et al. Mar 1989 A
4823791 D'Amelio et al. Apr 1989 A
4832048 Cohen May 1989 A
4860752 Turner Aug 1989 A
4931047 Broadwin et al. Jun 1990 A
4936301 Rexroth et al. Jun 1990 A
4943290 Rexroth et al. Jul 1990 A
4955377 Lennox et al. Sep 1990 A
4967765 Turner et al. Nov 1990 A
4968314 Michaels Nov 1990 A
4976711 Parins et al. Dec 1990 A
4979948 Geddes et al. Dec 1990 A
4998933 Eggers et al. Mar 1991 A
5007437 Sterzer Apr 1991 A
5007908 Rydell Apr 1991 A
5009656 Reimels Apr 1991 A
5035696 Rydell Jul 1991 A
5037421 Boutacoff et al. Aug 1991 A
5057105 Malone et al. Oct 1991 A
5057106 Kasevich et al. Oct 1991 A
5061266 Hakky Oct 1991 A
5078717 Parins et al. Jan 1992 A
5080660 Buelna Jan 1992 A
5083565 Parins Jan 1992 A
5085659 Rydell Feb 1992 A
5098431 Rydell Mar 1992 A
5102410 Dressel Apr 1992 A
5108391 Flachenecker et al. Apr 1992 A
5112330 Nishigaki et al. May 1992 A
5122138 Manwaring Jun 1992 A
5125928 Parins et al. Jun 1992 A
5147354 Boutacoff et al. Sep 1992 A
5151098 Loertscher Sep 1992 A
5171311 Rydell et al. Dec 1992 A
5176528 Fry et al. Jan 1993 A
5178620 Eggers et al. Jan 1993 A
5190517 Zieve et al. Mar 1993 A
5192280 Parins Mar 1993 A
5195959 Smith Mar 1993 A
5197466 Marchosky et al. Mar 1993 A
5197963 Parins Mar 1993 A
5207675 Canady May 1993 A
5217455 Tan Jun 1993 A
5217457 Delahuerga et al. Jun 1993 A
5249585 Turner et al. Oct 1993 A
5261410 Alfano et al. Nov 1993 A
5267994 Gentelia et al. Dec 1993 A
5267997 Farin et al. Dec 1993 A
5273524 Fox et al. Dec 1993 A
5277201 Stern Jan 1994 A
5281216 Klicek Jan 1994 A
5281218 Imran Jan 1994 A
5282797 Chess Feb 1994 A
5282799 Rydell Feb 1994 A
5290273 Tan Mar 1994 A
5290282 Casscells Mar 1994 A
5300069 Hunsberger et al. Apr 1994 A
5300099 Rudie Apr 1994 A
5301687 Wong et al. Apr 1994 A
5304170 Green Apr 1994 A
5312395 Tan et al. May 1994 A
5312400 Bales et al. May 1994 A
5314406 Arias et al. May 1994 A
5318563 Malis et al. Jun 1994 A
5322507 Costello et al. Jun 1994 A
5324254 Phillips Jun 1994 A
5330470 Hagen Jul 1994 A
5330518 Neilson et al. Jul 1994 A
5334140 Phillips Aug 1994 A
5334183 Wuchinich Aug 1994 A
5336217 Buys et al. Aug 1994 A
5336220 Ryan et al. Aug 1994 A
5342357 Nardella Aug 1994 A
5366443 Eggers et al. Nov 1994 A
5370642 Keller Dec 1994 A
5370675 Edwards et al. Dec 1994 A
5375588 Yoon Dec 1994 A
5380277 Phillips Jan 1995 A
5380316 Aita et al. Jan 1995 A
5383876 Nardella Jan 1995 A
5383917 Desai et al. Jan 1995 A
5389096 Aita et al. Feb 1995 A
5395312 Desai Mar 1995 A
5395363 Billings et al. Mar 1995 A
5417687 Nardella et al. May 1995 A
5419767 Eggers et al. May 1995 A
5423803 Tankovich et al. Jun 1995 A
5423810 Goble et al. Jun 1995 A
5423882 Jackman et al. Jun 1995 A
5436566 Thompson et al. Jul 1995 A
5438302 Goble Aug 1995 A
5441499 Fritzsch Aug 1995 A
5445634 Keller Aug 1995 A
5454809 Janssen Oct 1995 A
5462545 Wang et al. Oct 1995 A
5496312 Klicek Mar 1996 A
5514130 Baker May 1996 A
5556397 Long et al. Sep 1996 A
5569242 Lax et al. Oct 1996 A
5584872 LaFontaine et al. Dec 1996 A
5609151 Mulier et al. Mar 1997 A
5626576 Janssen May 1997 A
5647869 Goble et al. Jul 1997 A
5662680 Desai Sep 1997 A
5676693 LaFontaine Oct 1997 A
5683366 Eggers et al. Nov 1997 A
5697281 Eggers et al. Dec 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5700262 Acosta et al. Dec 1997 A
5725524 Mulier et al. Mar 1998 A
5749869 Lindenmeier et al. May 1998 A
5766153 Eggers et al. Jun 1998 A
5785705 Baker Jul 1998 A
5807395 Mulier et al. Sep 1998 A
5810764 Eggers et al. Sep 1998 A
5810809 Rydell Sep 1998 A
5843019 Eggers et al. Dec 1998 A
5860974 Abele Jan 1999 A
5871469 Eggers et al. Feb 1999 A
5871524 Knowlton Feb 1999 A
5873855 Eggers et al. Feb 1999 A
5885277 Korth Mar 1999 A
5888198 Eggers et al. Mar 1999 A
5891095 Eggers et al. Apr 1999 A
5893848 Negus et al. Apr 1999 A
5895386 Odell et al. Apr 1999 A
5897553 Mulier et al. Apr 1999 A
5902272 Eggers et al. May 1999 A
5904681 West, Jr. May 1999 A
5944715 Goble et al. Aug 1999 A
5976127 Lax Nov 1999 A
6004319 Goble et al. Dec 1999 A
6013076 Goble et al. Jan 2000 A
6015406 Goble et al. Jan 2000 A
6024733 Eggers et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6039734 Goble Mar 2000 A
6045532 Eggers et al. Apr 2000 A
6056746 Goble et al. May 2000 A
6063079 Hovda et al. May 2000 A
6066134 Eggers et al. May 2000 A
6068628 Fanton et al. May 2000 A
6074386 Goble et al. Jun 2000 A
6090106 Goble et al. Jul 2000 A
6093186 Goble Jul 2000 A
6102046 Weinstein et al. Aug 2000 A
6109268 Thapliyal et al. Aug 2000 A
6117109 Eggers et al. Sep 2000 A
6126682 Sharkey et al. Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6149620 Baker et al. Nov 2000 A
6156031 Aita et al. Dec 2000 A
6159194 Eggers et al. Dec 2000 A
6159208 Hovda et al. Dec 2000 A
6168593 Sharkey et al. Jan 2001 B1
6179824 Eggers et al. Jan 2001 B1
6179836 Eggers et al. Jan 2001 B1
6183469 Thapliyal et al. Feb 2001 B1
6190381 Olsen et al. Feb 2001 B1
6203542 Ellsberry et al. Mar 2001 B1
6210402 Olsen et al. Apr 2001 B1
6210405 Goble et al. Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6228081 Goble May 2001 B1
6234178 Goble et al. May 2001 B1
6235020 Cheng et al. May 2001 B1
6238391 Olsen et al. May 2001 B1
6254600 Willink et al. Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6264652 Eggers et al. Jul 2001 B1
6267757 Aita et al. Jul 2001 B1
6277112 Underwood et al. Aug 2001 B1
6283961 Underwood et al. Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6296636 Cheng et al. Oct 2001 B1
6296638 Davison et al. Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6312408 Eggers et al. Nov 2001 B1
6315774 Daniel et al. Nov 2001 B1
6322549 Eggers et al. Nov 2001 B1
6355032 Hovda et al. Mar 2002 B1
6363937 Hovda et al. Apr 2002 B1
6379350 Sharkey et al. Apr 2002 B1
6379351 Thapliyal et al. Apr 2002 B1
6391025 Weinstein et al. May 2002 B1
6391028 Fanton et al. May 2002 B1
6416507 Eggers et al. Jul 2002 B1
6416508 Eggers et al. Jul 2002 B1
6432103 Ellsberry et al. Aug 2002 B1
6514250 Jahns et al. Feb 2003 B1
6530922 Cosman et al. Mar 2003 B2
6557559 Eggers et al. May 2003 B1
20020026186 Woloszko et al. Feb 2002 A1
20020049438 Sharkey et al. Apr 2002 A1
Foreign Referenced Citations (56)
Number Date Country
3 930 451 Mar 1991 DE
515 867 Dec 1992 EP
0 597 463 May 1994 EP
0 650 701 May 1995 EP
0 703 461 Mar 1996 EP
0 740 926 Nov 1996 EP
0 740 926 Nov 1996 EP
0 754 437 Jan 1997 EP
0 923 907 Jun 1999 EP
0 694 290 Nov 2000 EP
1 149 564 Oct 2001 EP
2 313 949 Jan 1977 FR
2 308 979 Jul 1997 GB
2 308 980 Jul 1997 GB
2 308 981 Jul 1997 GB
2 327 350 Jan 1999 GB
2 327 351 Jan 1999 GB
2 327 352 Jan 1999 GB
2 379 878 Mar 2003 GB
57-57802 Apr 1982 JP
57-117843 Jul 1982 JP
9003152 Apr 1990 WO
WO 9007303 Jul 1990 WO
9113650 Sep 1991 WO
WO 9221278 Dec 1992 WO
WO 9313816 Jul 1993 WO
WO 9320747 Oct 1993 WO
9404220 Mar 1994 WO
9408654 Apr 1994 WO
WO 9414383 Jul 1994 WO
9426228 Nov 1994 WO
9505781 Mar 1995 WO
9505867 Mar 1995 WO
9530373 Nov 1995 WO
9534259 Dec 1995 WO
9600042 Jan 1996 WO
9607360 Mar 1996 WO
9634568 Nov 1996 WO
9700646 Jan 1997 WO
9700647 Jan 1997 WO
9715238 May 1997 WO
9724073 Jul 1997 WO
9724074 Jul 1997 WO
9724992 Jul 1997 WO
9724993 Jul 1997 WO
9724994 Jul 1997 WO
9741786 Nov 1997 WO
9748345 Dec 1997 WO
9748346 Dec 1997 WO
9807468 Feb 1998 WO
9814131 Apr 1998 WO
9827879 Jul 1998 WO
9827880 Jul 1998 WO
9951155 Oct 1999 WO
9951158 Oct 1999 WO
03024339 Mar 2003 WO
Non-Patent Literature Citations (51)
Entry
US 5,326,343, 7/1994, Rudie et al. (withdrawn)
V.E. Elsasser et al. Acta Medicotechnica 24(4):129-134 (1976).
M. Buchelt et al. Lasers In Surgery and Medecine 11:271-279 (1991).
J. Costello Lasers in Surgery and Medecine 12:121-124 (1992).
U.S. patent application Ser. No. 5,326,343, Rudie et al., filed Jul. 1994, (withdrawn).
P. Nardella SPIE 1068:42-49 (1989).
Rand et al. J. Arthro. Surg. 1:242-246 (1985).
E.V. Kramolowsky et al. J. of Urology vol. 143, pp. 275-277 (1990).
J.W. Ramsey et al. Urological Research vol. 13, pp. 99-102 (1985).
R. Tucker et al., Abstract P14-11, p. 248, “A Bipolar Electrosurgical Turp Loop”.
R. Tucker et al. J. of Urology vol. 141, pp. 662-665, (1989).
R. Tucker et al. Urological Research vol. 18, pp. 291-294 (1990).
Kramalowsky et al. (1991) J. of Urology 146:669-674.
Kramalowsky et al. (1989) J. of Urology 143:275-277.
Ramsay et al. (1985) Urological Research 13:99-102.
J. Pearce Electrosurgery, John Wiley & Sons, New York, 1986.
Slager et al. (1985) JACC 5(6):1382-6.
Slager et al. (1987) Z. Kardiol. 76:suppl. 6, 67-71.
Olsen MD, Bipolar Laparoscopic Cholecstectomy Lecture (marked confidential), Oct. 7, 1991.
Codman & Shurtleff, Inc. “The Malis Bipolar Electrosurgical System CMC-III Instruction Manual” Jul. 1991.
Valley Forge's New Products, CLINICA, 475, 5, Nov. 6, 1991.
Valley Forge Scientific Corp., “Summary of Safety and Effective Information from 510K,” 1991.
Codman & Shurtleff, Inc. “The Malis Bipolar Coagulating and Bipolar Cutting System CMC-II” brochure, early 1991.
L. Malis, “The Value of Irrigation During Bipolar Coagulation” See ARTC 21602, early Apr. 9, 1993.
L. Malis, “Excerpted from a seminar by Leonard I. Malis, M.D. at the 1995 American Associated of Neurological Surgeons Meeting,” 1995.
L. Malis, “Electrosurgery, Technical Note,” J. Neursurg., vol. 85, 970-975, 11/96.
Ian E. Shuman, “Bipolar Versus Monopolar Electrosurgery: Clinical Applications,” Dentistry Today, vol. 20, No. 12, 12/01.
Protell et al., “Computer-Assisted Electrocoagulation: Bipolar v. Monopolar in the Treatment of Experimental Canine Gastric Ulcer Bleeding,” Gastroenterology vol. 80, No. 3, pp. 451-455.
Cook and Webster, “Therapeutic Medical Devices: Application and Design,” 1992.
Valleylab SSE2L Instruction Manual, Jan. 6, 1983.
Robert D. Tucker et al., “Demodulated Low Frequency Currents from Electrosurgical Procedures,” Surgery, Gynecology and Obstetrics, 159:39-43, 1984.
Lu, et al., “Electrical Thermal Angioplasty: Catheter Design Features, In Vitro Tissue Ablation Studies and In Vitro Experimental Findings,” Am. J. Cardiol vol. 60, pp. 1117-1122.
Selikowitz & LaCourse, “Electric Current and Voltage Recordings on the Myocardium During Electrosurgical Procedures in Canines,” Surgery, Gynecology & Obstetrics, vol. 164, 219-224, Mar. 1987.
J. O'Malley, Schaum's Outline of Theory and Problems of Basic Circuit Analysis, McGraw-Hill, 2nd Ed., 1992, pp. 3-5.
Arnaud Wattiez et al., “Electrosurgery in Operative Endoscopy,” Electrosurgical Effects, Blackwell Science, pp. 85-93, 1995.
Leslie A. Geddes, “Medical Device Accidents: With Illustrative Cases” CRC Press, 1998.
Wyeth, “Electrosurgical Unit” pp. 1181-1202.
C.P. Swain, et al., Gut vol. 25, pp. 1424-1431 (1984).
Piercey et al., Gastroenterology vol. 74(3), pp. 527-534 (1978).
A.K. Dobbie Bio-Medical Engineering vol. 4, pp. 206-216 (1969).
B. Lee et al. JACC vol. 13(5), pp. 1167-1175 (1989).
K. Barry et al. American Heart Journal vol. 117, pp. 332-341 (1982).
W. Honig IEEE pp. 58-65 (1975).
Jacob Kline, Handbook of Biomedical Engineering, Academic Press Inc., N.Y., pp. 98-113, 1988.
M.B. Dennis et al. “Evolution of Electrofulguration in Control of Bleeding of Experimental Gastric Ulcers,” Digestive Diseases and Sciences, vol. 24, No. 11, 845-848.
Letter from Department of Health to Jerry Malis dated Apr. 15, 1985.
Letter from Jerry Malis to FDA dated Jul. 25, 1985.
Letter from Department of Health to Jerry Malis dated Apr. 22, 1991.
Leonard Malis, “Instrumenation for Microvascular Neurosurgery” Cerebrovascular Surgery, vol. 1, 245-260, 1985.
Valleylab, Inc. “Valleylab Part No. 945 100 102 A” Surgistat Service Manual, 7/88.
Leonard I. Malis, “New Trends in Microsurgery and Applied Technology,” Advanced Technology in Neurosurgery, 1-16, 1988.
Continuation in Parts (1)
Number Date Country
Parent 08/059681 May 1993 US
Child 08/446767 US